Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces and clinical sources (ventricular fluid - CCUG)
DNA G+C(%): 39.3-40.0
|
High T(℃): 42(neg)
pH 4.2-5.9: 5.0(neg)
Bile reaction(%): 40(+)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
ampicillin: Var(MIC50): 10; disc), MIC90: Var(10; disc
penicillin: R(10U)
|
cephalothin: R(30; disc)
|
amikacin: R(10; disc)
gentamicin: R(10; disc)
kanamycin: R(30; disc)
streptomycin: R(10; disc)
|
erythromycin: Var(MIC50): 15; disc), MIC90: Var(15; disc
|
nalidixic-acid: Var(MIC50): 30; disc), MIC90: Var(30; disc
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
tetracycline: Var(MIC50): 30; disc), MIC90: Var(30; disc
|
|
|
chloramphenicol: Var(MIC50): 30; disc), MIC90: Var(30; disc
sulfadiazine: Var(MIC50): 25; disc), MIC90: Var(25; disc
SXT: Var(MIC50): 25; disc), MIC90: Var(25; disc
|
clindamycin: Var(MIC50): 2; disc), MIC90: Var(2; disc
colistin: R(10; disc)
polymyxin_B: R(300; disc)
|